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Résumé en
anglais
Caveolin-1 (Cav1), a structural protein required for the formation of invaginated
membrane domains known as caveolae, has been implicated in cholesterol
trafficking and homeostasis. Here we investigated the contribution of Cav1 to
apolipoprotein A-I (apoA-I) cell surface binding and intracellular processing using
mouse embryonic fibroblasts (MEFs) derived from wild type (WT) or Cav1-deficient
(Cav1(-/-)) animals. We found that cells expressing Cav1 have 2.6-fold more apoA-I
binding sites than Cav1(-/-) cells although these additional binding sites are not
associated with detergent-free lipid rafts. Further, Cav1-mediated binding targets
apoA-I for internalization and degradation and these processes are not correlated to
cholesterol efflux. Despite lower apoA-I binding, cholesterol efflux from Cav1(-/-)
MEFs is 1.7-fold higher than from WT MEFs. Stimulation of ABCA1 expression with
an LXR agonist enhances cholesterol efflux from both WT and Cav1(-/-) cells without
increasing apoA-I surface binding or affecting apoA-I processing. Our results
indicate that there are at least two independent lipid binding sites for apoA-I; Cav1-
mediated apoA-I surface binding and uptake is not linked to cholesterol efflux,
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